Astellas Dublin has taken a major step forward in its sustainability journey with the completion of a 2.2MWp ground-mounted solar farm at its pharmaceutical manufacturing facility in Damastown, Dublin.
Delivered by Greenvolt Next in just four months, the new solar installation is now live and supplying 27% of the site’s electricity needs. The project is expected to save approximately 310 tonnes of CO₂ emissions each year, supporting Astellas Dublin’s efforts to reduce Scope 2 emissions and lower its reliance on grid electricity.
The fast-tracked project reflects the growing importance of renewable energy, energy resilience, and long-term sustainability for energy-intensive commercial and industrial sites.
A Major Renewable Energy
Investment for Astellas Dublin
Astellas Dublin operates a major pharmaceutical manufacturing facility in Damastown, where specialist production processes, site infrastructure, and operational reliability create significant and consistent electricity demand.
As part of Astellas’ wider commitment to contributing to the sustainability of society through its business activities, the Dublin site has invested in renewable energy infrastructure designed to support decarbonisation while maintaining the high standards required in pharmaceutical manufacturing.
The new ground-mounted solar farm was selected as a scalable and high-impact solution suited to the site’s available space and long-term energy needs.
3,192 Solar Panels Now
Powering the Damastown Site
The solar farm features 3,192 solar panels and five inverters, with an installed capacity of 2.2MWp. Greenvolt Next managed the full project lifecycle, from concept and design through to installation and commissioning.
The result is a renewable energy system that now supplies more than a quarter of the facility’s electricity needs.
2.2 MW
Installed Capacity
3,192
Installed solar panels
310 tons
CO2 avoided per year
5
Inverters
27%
Of site electricity needs supplied
4 months
Project delivery timeline
Supporting Energy Resilience and Emissions Reduction
The project was designed to address several important priorities for Astellas Dublin, including reducing Scope 2 CO₂ emissions, improving energy resilience, and providing greater control over electricity supply.
For pharmaceutical manufacturing sites, where operational reliability is critical, renewable energy infrastructure must be delivered without compromising site performance or compliance. Greenvolt Next’s delivery model enabled the project to move quickly from design to commissioning while supporting the operational needs of a live manufacturing environment.
At a time when energy market volatility and security of supply remain important considerations for businesses, the solar farm gives Astellas Dublin a more resilient and sustainable energy foundation.
Built for Future Growth
The system has also been designed with future expansion in mind. Its infrastructure can accommodate additional inverters and battery storage integration, giving Astellas Dublin the flexibility to increase its renewable energy capacity as site requirements evolve.
This future-ready approach means the project is not only delivering immediate emissions and energy benefits, but also creating a platform for further sustainability investment over time.
Biodiversity Built Into the Project
Sustainability considerations extended beyond renewable electricity generation. As part of the wider project, biodiversity enhancements were introduced across the site.
Large bug hotels were constructed using reclaimed tree stumps, multiple bat boxes were installed, and native Irish trees were planted to support local ecology and long-term biodiversity.
The solar farm is also visible from the site’s 1.1km riverwalk, giving employees and visitors a clear view of Astellas Dublin’s commitment to renewable energy and environmental stewardship.
Greenvolt Next to Provide Ongoing Support
Following commissioning, Greenvolt Next will continue to support Astellas Dublin through ongoing maintenance and performance reviews. This will help ensure the solar farm continues to operate effectively and deliver long-term value for the site.
The completion of the 2.2MWp solar farm marks a significant milestone for Astellas Dublin, demonstrating how large-scale renewable energy can be delivered quickly, efficiently, and in alignment with the operational demands of a major pharmaceutical manufacturing facility.
With measurable emissions savings, improved energy resilience, biodiversity benefits, and future scalability, the project provides a strong foundation for the site’s continued sustainability journey.
